YANPING LI

Counsel·Shenzhen

YANPING LI

Counsel·Shenzhen

YANPING LI

Counsel·Shenzhen

PROFILE REPRESENTATIVE MATTERS AND CASES OTHER INFORMATION Further Reading

MS. LI’S PRACTICE FOCUSES ON PRIVATE EQUITY INVESTMENT AND FINANCING, M&A, RESTRUCTURING, INVESTMENT FUNDS AND GERNAL CORPORATE. SHE PARTICIPATES IN NUMEROUS DOMESTIC AND CROSS-BORDER EQUITY TRANSACTIONS AND REPRESENTSAND MAINTAINS LONG-TERM AND DEEP COOPERATION WITH MANY INDUSTRIAL COMPANIES, INVESTMENT INSTITUTIONS, MULTINATIONAL CORPORATIONS AND LISTED COMPANIES.

Education

Peking University, School of Law, LL.M.

China University of Political Science and Law, LL.B.

Professional Qualification

Admitted to practice in the PRC

Professional Background

Ms. Li joined Fangda in 2015.

PROFILE

REPRESENTATIVE MATTERS AND CASES

  • Private Equity Financing & Investment

  • M&A

  • Investment Funds

  • Represented SeeYA Technology (688781.SH) in its several rounds of equity financing, its equity restructuring and reform and strategic investments.
  • Represented ASMPT Limited (0522.HK) in its restructuring of semiconductor solution business in China and incorporation of ASMPT SEMI Equipment, a leading semiconductor equipment supplier. 
  • Represented ASMPT Limited (0522.HK) in its establishment with Wise Road Capital of a joint venture Semiconductor Wet Advanced Technology.
  • Represented Alibaba Cloud in its investment in X Square Robot.
  • Represented CICC Capital in its investment in Cardiolink Science.
  • Represented CICC Capital in its investment in Convenient Power.
  • Represented China Merchants Capital in its investment in AnHeart Therapeutics, and the subsequent red-chip restructuring of AnHeart Therapeutics.
  • Represented Overseas Chinese Town Capital in its strategic investment in the equity reform program of China SDIC Gaoxin Industrial Investment.
  • Represented YF Capital in its investment in Whale House Tech.
  • Represented Mindray (300760.SZ) in its pre-IPO financing from over 20 investors.
  • Represented Migrasome Therapeutics in its Pre-A round financing.
  • Represented SeeYA Technology (688781.SH) in its investment in XReal and RayPai. 
  • Represented SeeYA Technology (688781.SH), Mindray (300760.SZ), iRay Technology (688301.SH) and NanoVision respectively in their ESOP matters.
  • Represented multiple multinational corporations in their investments and joint venture matters within the PRC, including MKS Instruments (NASDAQ: MKSI), Singapore Post Ltd (S08.SI) and DFI Retail (SGX:D01).
  • Represented ASMPT Limited (0522.HK) in its restructuring of global semiconductors materials business and its USD200 million sale of the controlling stake in the business.
  • Represented ASMPT Limited (0522.HK) in its strategic acquisitions of 100% shares respectively in SKTMAX (a leading provider of manufacturing execution system solutions) and Borey (a provider of SMT solutions).
  • Represented China Tourism Group Finance Investment Co., Ltd. in its acquisition of 100% shares respectively in Kai Fu Property Services Co., Ltd and Wilson Service Limited.
  • Represented a listed company in its proposed acquisition of a leading fintech company.
  • Represented iRay Technology (688301.SH) in its strategic acquisitions of majority shares respectively in Haiwei Technology and Hongzhi New Material.
  • Represented Fussen Technology in its acquisition of majority shares in the PRC subsidiary of Cortex, a leading Israeli dental implants company.
  • Represented Alibaba Pictures (1060.HK) in its RMB830 million acquisition of 100% shares in Yueke Software.
  • Represented a technology company in its proposed acquisition of the Asia-based TDDI business of Synaptics Incorporated (NASDAQ: SYNA).
  • Represented a listed company in its proposed acquisition of certain US assets and business of GE HealthCare (NASDAQ: GEHC).
  • Represented CICC Capital, China Merchants Capital and China Resources Capital respectively in forming several PE investment funds.
  • Represented CICC Capital, China Merchants Capital and Tianyi Capital respectively in their investment (as limited partner) in dozens of PE investment funds.
  • Represented Coller Capital in its acquisition of secondary interests in several PE funds.
  • Represented China Merchants Capital and Great Wall Asset Management respectively in their proposed 100% acquisition of secondary interests in several PE funds.
  • Represented Edge Ventures in its fundraising, equity investment, post-investment management and compliance matters.
  • Represented iRay Technology (688301.SH), SeeYA Technology (688781.SH) and Carbon Cloud Technology respectively in their investments in several PE funds.

OTHER INFORMATION